Drs. Yiu and Emami wrap-up their discussion of the 49th Annual Macula Society Meeting, focusing on new and emerging treatments for retinal diseases—such as gene therapies and longer‑acting eye injections—and reflect on both their promise and current limitations. They note that while these advances, along with tools like AI and multi-omics, are exciting, they are only beginning to influence everyday clinical practice and patient counseling.
Podden och tillhörande omslagsbild på den här sidan tillhör
PeerDirect. Innehållet i podden är skapat av PeerDirect och inte av,
eller tillsammans med, Poddtoppen.
